Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s226404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Circulating Antibodies to P16 Protein-Derived Peptides in Breast Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Reply To: “Diagnostic and Prognostic Role of Circulating Microparticles in Hepatocellular Carcinoma”

Journal of Hepatology
Hepatology
2018English

Accumulation Mechanisms of CD4+CD25+FOXP3+ Regulatory T Cells in EBV-associated Gastric Carcinoma

Scientific Reports
Multidisciplinary
2015English

Soluble CD25 as a Predictor of Hepatocellular Carcinoma Compared With Alpha-Fetoprotein

Clinical and Experimental Hepatology
Hepatology
2019English

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook

Frontiers in Medicine
Medicine
2018English

Circulating AIM Prevents Hepatocellular Carcinoma Through Complement Activation

Cell Reports
BiochemistryGeneticsMolecular Biology
2014English

Molecular Mechanism Underlying the Functional Loss of Cyclindependent Kinase Inhibitors P16 and P27 in Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2008English

FOXP3 Gene Polymorphism Is Associated With Hepatitis B-Related Hepatocellular Carcinoma in China

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

Cytological Study of Hepatocellular Carcinoma.

The Journal of the Japanese Society of Clinical Cytology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy